BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19718792)

  • 1. Insulin-loaded microcapsules for in vivo delivery.
    Kim BS; Oh JM; Hyun H; Kim KS; Lee SH; Kim YH; Park K; Lee HB; Kim MS
    Mol Pharm; 2009; 6(2):353-65. PubMed ID: 19718792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BSA-FITC-loaded microcapsules for in vivo delivery.
    Kim BS; Oh JM; Kim KS; Seo KS; Cho JS; Khang G; Lee HB; Park K; Kim MS
    Biomaterials; 2009 Feb; 30(5):902-9. PubMed ID: 19027943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
    Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo.
    Takenaga M; Yamaguchi Y; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Pharm Pharmacol; 2002 Sep; 54(9):1189-94. PubMed ID: 12356272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new animal model for evaluation of long-term growth rate over one month by rhGH/PLGA microcapsule formulations.
    Takada S; Kurokawa T; Misaki M; Taira K; Yamagata Y
    J Pharm Pharmacol; 2003 Jul; 55(7):951-61. PubMed ID: 12906752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization and in vivo evaluation of pH-sensitive oral insulin-loaded poly(lactic-co-glycolicacid) nanoparticles.
    Yang J; Sun H; Song C
    Diabetes Obes Metab; 2012 Apr; 14(4):358-64. PubMed ID: 22151795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PEGylated insulin in PLGA microparticles. In vivo and in vitro analysis.
    Hinds KD; Campbell KM; Holland KM; Lewis DH; Piché CA; Schmidt PG
    J Control Release; 2005 Jun; 104(3):447-60. PubMed ID: 15911045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Int J Pharm; 2010 Apr; 389(1-2):74-85. PubMed ID: 20085803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of insulin from pH/temperature-sensitive injectable pentablock copolymer hydrogel.
    Huynh DP; Im GJ; Chae SY; Lee KC; Lee DS
    J Control Release; 2009 Jul; 137(1):20-4. PubMed ID: 19285530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of PEGDMA: MAA based hydrogel microparticles for oral insulin delivery.
    Kumar A; Lahiri SS; Singh H
    Int J Pharm; 2006 Oct; 323(1-2):117-24. PubMed ID: 16828246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained topical delivery of insulin from fibrin gel loaded with poly(lactic-co-glycolic Acid) microspheres improves the biomechanical retention of titanium implants in type 1 diabetic rats.
    Han Y; Zeng Q; E L; Wang D; He H; Liu H
    J Oral Maxillofac Surg; 2012 Oct; 70(10):2299-308. PubMed ID: 22871310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
    Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
    J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tetrandrine loaded sustained-release microcapsules for lung targeting].
    Li FQ; Lu B; Chen WB; Yang H
    Yao Xue Xue Bao; 2001 Mar; 36(3):220-3. PubMed ID: 12580092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
    Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
    J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
    Salmaso S; Bersani S; Elvassore N; Bertucco A; Caliceti P
    Int J Pharm; 2009 Sep; 379(1):51-8. PubMed ID: 19545616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.